{"gene":"UBE2D2","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":1990,"finding":"Yeast UBC4 and UBC5 (orthologues of human UBE2D2) are ubiquitin-conjugating enzymes that mediate selective degradation of short-lived and abnormal proteins; they are heat-inducible, generate high-molecular-weight ubiquitin-protein conjugates in vivo, and their loss impairs cell growth and stress tolerance.","method":"Genetic deletion (ubc4ubc5 mutants), in vivo ubiquitin conjugation assays, protein turnover measurements","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — foundational study with multiple orthogonal methods; replicated across many subsequent studies","pmids":["2154373"],"is_preprint":false},{"year":1993,"finding":"The three-dimensional structure of yeast Ubc4 (UBE2D2 orthologue) was solved at 2.7 Å; it is an α/β protein with four α-helices and a four-stranded antiparallel β-sheet, with the ubiquitin-accepting catalytic cysteine located in a cleft between two loops. Tertiary structure is highly conserved among class I E2 enzymes, and a conserved surface adjacent to the catalytic cysteine mediates protein-protein interactions during ubiquitin thioester formation.","method":"X-ray crystallography (molecular replacement, 2.7 Å resolution)","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional interpretation, foundational structural paper","pmids":["8268156"],"is_preprint":false},{"year":1995,"finding":"Human UBC4 (UBE2D2) specifically ubiquitinates E6-associated protein (E6AP) and is required for HPV E6/E6AP-mediated ubiquitination and degradation of p53 in vitro; inhibition of UBC4 activity in vivo blocks E6-stimulated p53 degradation, defining UBC4 as the E2 in this pathway.","method":"Reconstitution of ubiquitination from purified components, in vivo inhibition assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution from purified components with in vivo validation","pmids":["7724550"],"is_preprint":false},{"year":1995,"finding":"Yeast UBC4 monoubiquitinates itself in vivo at Lys144 via an intermolecular (E2–E2) reaction requiring a second lysine (K64) and direct homointeraction between UBC4 monomers, demonstrating E2–E2 interactions as a general phenomenon.","method":"Epitope-tagged ubiquitin co-expression, site-directed mutagenesis, chemical mapping, cross-linking analysis","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal mutagenesis and cross-linking in single study","pmids":["7756256"],"is_preprint":false},{"year":1999,"finding":"c-Cbl functions as a RING-type E3 ubiquitin ligase that recruits and allosterically activates an E2 ubiquitin-conjugating enzyme (Ubc4/5 family, including UBE2D2 orthologue) through its RING domain to ubiquitinate tyrosine-phosphorylated receptor protein-tyrosine kinase substrates.","method":"In vitro ubiquitination assays, co-immunoprecipitation, RING domain mutagenesis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted activity with mutagenesis, highly cited foundational paper","pmids":["10514377"],"is_preprint":false},{"year":2000,"finding":"APC11 (RING-H2 finger subunit of the APC/C) together with UBC4 (UBE2D2 orthologue) is sufficient to ubiquitinate APC/C substrates cyclin B and securin in vitro, and to synthesize multiubiquitin chains; the integrity of the RING-H2 finger is required for this activity.","method":"Reconstitution of ubiquitination with recombinant proteins, mass spectrometry identification, RING domain mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution with mutagenesis validation","pmids":["10922056"],"is_preprint":false},{"year":2000,"finding":"UBC4 (UBE2D2 orthologue) cooperates with SCF(β-TRCP) E3 complex to catalyze phosphorylation-dependent ubiquitination of IκBα in a reconstituted system; Ubc4 is 19-fold more efficient than Ubc3/CDC34 in this reaction and is in excess over Ubc3 in THP.1 cells, suggesting it is the preferentially used E2 in vivo. Both E2s associate physically with the SCF(β-TRCP) complex.","method":"Reconstitution of IκBα ubiquitination from recombinant components, co-immunoprecipitation with SCF complex from human cells, activity comparison assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution with quantitative comparison and co-IP validation","pmids":["10918611"],"is_preprint":false},{"year":2003,"finding":"In fission yeast, UbcP1/Ubc4 (UBE2D2 orthologue) and UbcP4/Ubc11 play non-redundant, essential roles in mitotic cyclin Cdc13 degradation via APC/C; Ubc4 specifically elongates short ubiquitin chains initiated by UbcP4/Ubc11, demonstrating distinct roles for the two E2s in polyubiquitin chain assembly on APC/C substrates.","method":"Genetic analysis (mutant phenotypes, non-complementation), in vivo ubiquitination state analysis of Cdc13","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with direct in vivo ubiquitination analysis, replicated in multiple genetic contexts","pmids":["12724408"],"is_preprint":false},{"year":2004,"finding":"UbcH5B (UBE2D2) supports Mdm2-mediated ubiquitination of p53 and Mdm2 auto-ubiquitination in vitro; siRNA knockdown of UbcH5B/C in cells causes accumulation of both Mdm2 and p53, inhibits p53 ubiquitination and degradation, identifying UbcH5B/C as physiological E2s for Mdm2 in maintaining low p53/Mdm2 levels in unstressed cells.","method":"In vitro E2 panel screen, siRNA knockdown, p53/Mdm2 protein level and ubiquitination analysis in intact cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution plus RNAi with cellular phenotype, multiple orthogonal methods","pmids":["15280377"],"is_preprint":false},{"year":2004,"finding":"The solution structure of UbcH5B (UBE2D2) was determined by NMR; the structure shows the conserved E2 fold but with a distinct orientation of the N-terminal helix (involved in E3 binding) compared to crystal structures, and conformational freedom of the catalytic Asn77 side chain, which may have implications for catalytic mechanism.","method":"NMR spectroscopy (homology modeling, relaxation data, automated NOE assignments)","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — NMR structure determination with functional discussion","pmids":["15522302"],"is_preprint":false},{"year":2004,"finding":"The structural model of the UbcH5B (UBE2D2)/CNOT4 RING complex was determined by NMR chemical shift perturbation mapping of UbcH5B residues important for CNOT4 binding, combined with HADDOCK docking; the model reveals E2/E3 interface residues and differences from the c-Cbl/UbcH7 complex that underlie E2–E3 specificity.","method":"NMR chemical shift perturbation experiments, computational docking (HADDOCK), mutagenesis","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — NMR-driven structural model with mutagenesis validation","pmids":["15062086"],"is_preprint":false},{"year":2008,"finding":"UBE2D2 is responsible for SCF(FBXW2)-mediated ubiquitination and proteasomal degradation of the placental transcription factor GCM1; UBE2D2 enzyme activity is required for GCMa ubiquitination, UBE2D2 associates with the SCF(FBXW2) complex, and RNAi knockdown of UBE2D2 prolongs GCM1 half-life in vivo.","method":"In vitro ubiquitination assay screen, co-immunoprecipitation, RNAi knockdown with protein half-life measurement","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution, co-IP, and RNAi with substrate stabilization in cells","pmids":["18703417"],"is_preprint":false},{"year":2008,"finding":"Ubc4/5 (UBE2D2 orthologue) cooperates with c-Cbl E3 ligase to ubiquitinate the EGF receptor (EGFR) both at the plasma membrane and after internalization on Hrs-positive endosomes; sustained EGFR tyrosine phosphorylation facilitates polyubiquitination in endosomes, which is required for efficient Hrs interaction and lysosomal sorting.","method":"Localization studies (fluorescence microscopy), siRNA knockdown, in vitro ubiquitination assays, time-course analysis of EGFR ubiquitination and trafficking","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including knockdown, localization, and in vitro activity","pmids":["18508924"],"is_preprint":false},{"year":2010,"finding":"Crystal structure of UbcH5b (UBE2D2)~ubiquitin intermediate at 2.2 Å reveals the E2~Ub conjugate self-assembles into an infinite spiral through a backside interaction; this assembly provides multiple active E2 sites, and biochemical assays support a model in which self-assembled UbcH5b~Ub bridges the gap between substrate lysine and the E2 catalytic cysteine to enable efficient ubiquitination.","method":"X-ray crystallography (2.2 Å), in vitro ubiquitination assays","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus biochemical validation in one study","pmids":["20152160"],"is_preprint":false},{"year":2010,"finding":"The E4B U box domain (E3/E4 ubiquitin ligase) binds UbcH5c and Ubc4 (UBE2D2 family) as a monomer; crystal and NMR structures of E4B U box free and bound to UbcH5c/Ubc4 reveal an allosteric regulation of the E2 enzymes by E4B U box, providing a molecular basis for assembly of the ubiquitylation machinery involving E4B.","method":"X-ray crystallography, NMR spectroscopy, calorimetry-based binding assays","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — multiple structural methods plus biophysical binding measurements","pmids":["20696396"],"is_preprint":false},{"year":2011,"finding":"In yeast, the essential function of Ubc4/Ubc5 (UBE2D2 orthologues) is with a HECT-type E3 (likely the essential HECT E3 Rsp5), not RING E3s; the N78S mutation selectively eliminating RING-catalyzed isopeptide bond formation (but not HECT transthiolation) rescues the lethal ubc4/ubc5 deletion. In RING E3-catalyzed pathways Ubc4 acts as a monoubiquitinating E2, and backside ubiquitin binding (S23R mutation) has no observable in vivo effect.","method":"Yeast genetic rescue assays with point mutations, in vitro reconstitution distinguishing HECT vs RING pathways","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — genetic epistasis combined with biochemical reconstitution and mutagenesis","pmids":["21357418"],"is_preprint":false},{"year":2014,"finding":"UBE2D2 (along with UBE2N and UBE2L3) is required for Parkin-dependent mitophagy; knockdown of UBE2D2/UBE2D3 reduces autophagic clearance of depolarized mitochondria without affecting PINK1 stabilization or Parkin translocation. Combined knockdown of all three E2s significantly reduces mitochondrial polyubiquitylation and p62 recruitment. UBE2D2 contributes to ubiquitination of mitofusins, TOM20, TOM70, VDAC1, and Parkin itself.","method":"siRNA knockdown, mitophagy assays, ubiquitination analysis of mitochondrial substrates, epistasis analysis with Parkin C431S mutant","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — multiple knockdowns with defined mitochondrial substrate phenotypes and epistasis with Parkin active-site mutant","pmids":["24906799"],"is_preprint":false},{"year":2015,"finding":"The RING E3 AO7 (RNF25) binds UbcH5B (UBE2D2) with unusually high affinity via a unique UbcH5B-binding region (U5BR) connected to the RING domain, forming a clamp surrounding the E2 and engaging both the RING-interacting surface and the backside of UbcH5B. High-affinity clamp binding paradoxically decreases ubiquitination rate by blocking stimulatory non-covalent ubiquitin binding to the UbcH5B backside; when backside binding cannot occur, the clamp enhances ubiquitination.","method":"Co-crystallization of AO7/UbcH5B complex, mutagenesis of RING-E2 interface, in vitro ubiquitination rate assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — co-crystal structure plus functional mutagenesis and quantitative activity assays","pmids":["26475854"],"is_preprint":false},{"year":2016,"finding":"UBE2D2 does not interact with the muscle-specific E3 ligase MuRF1 (no binding detected by yeast two-hybrid or Surface Plasmon Resonance) and is unable to promote degradation of the MuRF1 substrate α-actin in cells; UBE2D2 mRNA is progressively repressed during muscle atrophy, making it a poor candidate for MuRF1-dependent muscle wasting.","method":"Yeast two-hybrid, Surface Plasmon Resonance, HEK293T cell degradation assays, mRNA expression analysis during hindlimb suspension","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal binding assays plus functional cell assay, single lab","pmids":["27378730"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of cIAP1 RING dimer bound to UbcH5B (UBE2D2) covalently linked to ubiquitin and a noncovalent ubiquitin at 1.7 Å reveals that cIAP1 RING promotes a closed UbcH5B~Ub conformation priming the thioester for transfer; noncovalent ubiquitin binds the backside of UbcH5B and contacts the α1β1-loop, further stabilizing the closed active conformation.","method":"X-ray crystallography (1.7 Å), in vitro ubiquitin transfer assays, biochemical analysis of UbcH5B conformation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with biochemical validation","pmids":["30523153"],"is_preprint":false},{"year":2021,"finding":"UbcH5b (UBE2D2) strongly supports HECTD3 auto-ubiquitination in vitro; the triterpenoid PC3-15 directly binds UbcH5b and inhibits UbcH5b-mediated ubiquitination. The UbcH5b–p62 axis confers TNBC resistance to lapatinib by promoting autophagy; PC3-15 inhibits lapatinib-induced autophagy and restores lapatinib sensitivity in vitro and in mouse xenografts.","method":"FRET-based ubiquitination assay, direct binding assay (PC3-15 to UbcH5b), p62 ubiquitination assay, cell viability/autophagy assays, xenograft experiments","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro assays with direct binding and in vivo xenograft validation, single lab","pmids":["33607208"],"is_preprint":false},{"year":2021,"finding":"miR-30b-5p upregulated by ox-LDL reduces UBE2D2 ubiquitination activity, leading to stabilization of KAT2B, which promotes HMGB1 acetylation, nuclear exit, and secretion from endothelial cells, driving pro-inflammatory M1 macrophage polarization; UBE2D2 thus acts upstream of KAT2B in this inflammatory signaling pathway.","method":"Luciferase reporter assay (miR-30b-5p binding to UBE2D2), co-IP, ubiquitination assays, flow cytometry, Transwell migration","journal":"Atherosclerosis","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple methods but pathway mechanistic chain depends on several steps, single lab","pmids":["33812169"],"is_preprint":false},{"year":2022,"finding":"The RING domain of MUL1 (mitochondrial E3 ligase) recruits UBE2D2 and the substrate p53-TAD as a ternary complex; RING(MUL1) binding induces closed conformation of UBE2D2~Ub and strongly accelerates hydrolysis (ubiquitin transfer); the N77A mutation of UBE2D2 pre-forms the closed conformation even without RING(MUL1). TADp53 binding affinity is enhanced when presented to the RING(MUL1):UBE2D2~Ub complex (multivalent recognition of disordered substrate).","method":"Crystal structure determination (RING(MUL1):UBE2D2 complex), oxyester hydrolysis assays, binding affinity measurements, UBE2D2 mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mutagenesis and quantitative biochemical assays in one study","pmids":["35048531"],"is_preprint":false},{"year":2023,"finding":"UBE2D2 (and UBE2D1) regulate VEGFR2 ubiquitination and proteolysis in endothelial cells; depletion of UBE2D2 increases steady-state and plasma membrane VEGFR2 levels, enhances VEGF-A-stimulated MAPK/PLCγ1/Akt signaling, increases VEGFR2 recycling to the plasma membrane, and stimulates endothelial tubulogenesis.","method":"Reverse genetics siRNA screen, surface biotinylation, recycling assays, western blotting, tubulogenesis assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cellular methods with defined receptor trafficking phenotype, single lab","pmids":["37226882"],"is_preprint":false},{"year":2024,"finding":"Ubiquitin variants (UbVs) that bind Ube2d2 (UbcH5b) with low micromolar affinity and high specificity were identified; structural and biophysical characterization shows two UbVs inhibit ubiquitin chain building — one blocks the E1-binding site and a second additional site blocks non-covalent ubiquitin backside binding on Ube2d2, demonstrating the functional importance of both interfaces for E2 activity.","method":"Structural characterization, biophysical binding assays, in vitro ubiquitin chain-building inhibition assays, mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — structural and biophysical characterization with functional inhibition assays","pmids":["39473070"],"is_preprint":false},{"year":2003,"finding":"CHIP E3 ubiquitin ligase together with Hsc70 and the E2 enzyme UbcH5B (UBE2D2) ubiquitinates phosphorylated tau (an Alzheimer's disease-associated modification); phosphorylation of tau is a recognition requirement for CHIP/UbcH5B-mediated ubiquitination, and CHIP rescues phosphorylated tau-induced cell death.","method":"In vitro ubiquitination assay (co-incubation of purified components), cell death rescue assay, comparison with other E3 ligases","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified components, functional cell rescue, specificity demonstrated by comparison with other E3s","pmids":["14612456"],"is_preprint":false},{"year":2025,"finding":"UBE2D2 promotes gastric cancer progression by supporting autophagy-dependent stabilization of CST1 (Cystatin SN); UBE2D2 knockdown destabilizes GPx4 via the CST1 axis, enhancing ROS accumulation and ferroptosis. UBE2D2 knockdown suppresses GC cell proliferation, invasion, migration, and EMT in vitro and in vivo.","method":"Proteomic screening, UBE2D2 knockdown in vitro and in vivo (xenograft), ferroptosis assays (ROS, GPx4), mechanistic pathway validation","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2–3 — knockdown with defined pathway and substrate, single lab, mechanistic chain involves multiple steps","pmids":["40912429"],"is_preprint":false}],"current_model":"UBE2D2 (UbcH5B/UBC4) is a broadly acting E2 ubiquitin-conjugating enzyme whose conserved UBC domain harbors a catalytic cysteine in a surface cleft; it forms thioester intermediates with ubiquitin that adopt a stimulatory closed conformation upon RING E3 binding (structurally defined with APC11, cIAP1, AO7, MUL1, and E4B), supports ubiquitination of diverse substrates (p53 via Mdm2/E6AP/MUL1/COP1, GCM1 via SCF-FBXW2, IκBα via SCF-β-TRCP, EGFR via c-Cbl, phospho-tau via CHIP, mitofusins/TOM20/TOM70 via Parkin, and VEGFR2) through both RING and HECT E3 ligases, functions as a monoubiquitinating initiator in RING pathways while performing polyubiquitin chain elongation in HECT-dependent pathways, and is regulated by non-covalent ubiquitin backside binding that stimulates its activity as well as by miR-30b-5p-mediated suppression in inflammatory contexts."},"narrative":{"teleology":[{"year":1990,"claim":"Identification of UBC4/UBC5 in yeast established that a dedicated family of E2 enzymes mediates selective degradation of short-lived and abnormal proteins under stress, providing the first functional framework for UBE2D2 orthologues.","evidence":"Genetic deletion of yeast ubc4/ubc5 with in vivo ubiquitin conjugation and protein turnover assays","pmids":["2154373"],"confidence":"High","gaps":["Mammalian orthologues not yet characterized","E3 partners unknown","Substrate specificity determinants undefined"]},{"year":1993,"claim":"The crystal structure of Ubc4 at 2.7 Å revealed the canonical α/β E2 fold with the catalytic cysteine positioned in a surface cleft between two loops, explaining how the active site is accessible for thioester formation and E3 interaction.","evidence":"X-ray crystallography of yeast Ubc4 at 2.7 Å resolution","pmids":["8268156"],"confidence":"High","gaps":["No E3-bound structure yet","Mechanism of ubiquitin transfer from thioester not resolved"]},{"year":1995,"claim":"Biochemical reconstitution demonstrated that human UBE2D2 is the specific E2 for E6AP/E6-mediated p53 ubiquitination and degradation, establishing UBE2D2 as a physiologically relevant E2 in a disease-linked HECT E3 pathway.","evidence":"Reconstitution from purified components with in vivo inhibition of E2 activity","pmids":["7724550"],"confidence":"High","gaps":["RING vs HECT pathway distinction for UBE2D2 not yet made","Self-ubiquitination mechanism unclear"]},{"year":1999,"claim":"Discovery that c-Cbl RING domain recruits and allosterically activates UBE2D2-family E2s to ubiquitinate receptor tyrosine kinases revealed the paradigm of RING E3-mediated E2 activation, expanded UBE2D2 function to receptor signaling.","evidence":"In vitro ubiquitination, co-immunoprecipitation, RING domain mutagenesis","pmids":["10514377"],"confidence":"High","gaps":["Structural basis of RING-induced E2 activation not yet determined","In vivo confirmation of E2 identity pending"]},{"year":2000,"claim":"UBE2D2 orthologues were shown to function with APC/C (via APC11 RING) for cyclin B/securin ubiquitination and with SCF(β-TrCP) for phospho-IκBα ubiquitination, demonstrating that a single E2 services multiple major cell-cycle and NF-κB signaling E3 complexes.","evidence":"Biochemical reconstitution with recombinant APC11 and SCF complexes, quantitative activity comparison","pmids":["10922056","10918611"],"confidence":"High","gaps":["Whether UBE2D2 initiates or elongates ubiquitin chains in these pathways unresolved","Redundancy among UBE2D family members not dissected"]},{"year":2003,"claim":"Two studies established additional physiological E3 partnerships: CHIP/Hsc70 uses UBE2D2 to ubiquitinate phospho-tau, and fission yeast genetics revealed that Ubc4 specifically elongates ubiquitin chains on APC/C substrates after initiation by a distinct E2.","evidence":"In vitro reconstitution with purified CHIP/tau; genetic epistasis and in vivo ubiquitination state analysis in S. pombe","pmids":["14612456","12724408"],"confidence":"High","gaps":["Whether chain elongation role applies in mammalian APC/C pathway unknown","Tau ubiquitination in vivo dependence on UBE2D2 not shown"]},{"year":2004,"claim":"UBE2D2 was confirmed as the physiological E2 for Mdm2-dependent p53 ubiquitination by combining in vitro reconstitution with siRNA knockdown that stabilized both p53 and Mdm2 in cells; NMR solution structure provided the first human UBE2D2 atomic model.","evidence":"E2 panel screen, siRNA in human cells, NMR structure determination, NMR-based E3-interaction mapping with CNOT4","pmids":["15280377","15522302","15062086"],"confidence":"High","gaps":["How Mdm2 selects UBE2D2 over other E2s in vivo unclear","Catalytic role of Asn77 not experimentally resolved"]},{"year":2008,"claim":"UBE2D2 was linked to receptor trafficking via c-Cbl-mediated EGFR ubiquitination at the plasma membrane and on endosomes, and to placental biology via SCF(FBXW2)-dependent degradation of GCM1, broadening the physiological context of this E2.","evidence":"siRNA knockdown with EGFR trafficking analysis; in vitro ubiquitination, co-IP, RNAi with GCM1 half-life measurement","pmids":["18508924","18703417"],"confidence":"High","gaps":["Redundancy between UBE2D family members in EGFR pathway not resolved","Structural basis of SCF(FBXW2)–UBE2D2 interaction not determined"]},{"year":2010,"claim":"The 2.2 Å crystal structure of UBE2D2~ubiquitin conjugate revealed a self-assembling spiral mediated by non-covalent backside ubiquitin binding, providing a structural mechanism for how E2~Ub oligomerization bridges substrate lysine to the catalytic cysteine.","evidence":"X-ray crystallography at 2.2 Å with in vitro ubiquitination assays","pmids":["20152160"],"confidence":"High","gaps":["Physiological relevance of spiral assembly in vivo uncertain","Whether all RING E3s use this mechanism unknown"]},{"year":2011,"claim":"Yeast genetic dissection revealed that the essential function of UBE2D2 orthologues is with HECT-type E3s (likely Rsp5), not RING E3s, and that UBE2D2 acts as a monoubiquitinating E2 in RING pathways while performing chain elongation in HECT pathways — the N78S mutation selectively ablated RING- but not HECT-dependent activity.","evidence":"Yeast genetic rescue with separation-of-function mutations, in vitro reconstitution distinguishing HECT vs RING pathways","pmids":["21357418"],"confidence":"High","gaps":["Whether this HECT-preference applies in mammalian cells untested","In vivo relevance of backside ubiquitin binding contradicted by S23R having no phenotype"]},{"year":2014,"claim":"UBE2D2 was identified as one of three E2s required for Parkin-dependent mitophagy, contributing to ubiquitination of mitofusins, TOM20, TOM70, VDAC1, and Parkin itself, placing UBE2D2 in the PINK1/Parkin mitochondrial quality control pathway.","evidence":"siRNA knockdown with mitophagy assays, mitochondrial substrate ubiquitination analysis, epistasis with Parkin active-site mutant","pmids":["24906799"],"confidence":"High","gaps":["Relative contributions of UBE2D2 vs UBE2N vs UBE2L3 to specific substrates unclear","Whether UBE2D2 is recruited directly by Parkin RING or indirectly not resolved"]},{"year":2015,"claim":"Co-crystal structure of AO7/RNF25 with UBE2D2 revealed a unique clamp mechanism where a U5BR region engages the E2 backside, paradoxically inhibiting activity by blocking stimulatory non-covalent ubiquitin binding — demonstrating that E3s can tune E2 activity by competing for the backside surface.","evidence":"Co-crystallization, RING-E2 interface mutagenesis, quantitative ubiquitination rate assays","pmids":["26475854"],"confidence":"High","gaps":["Whether other E3s use analogous clamp mechanisms unknown","Physiological substrates of AO7/UBE2D2 not identified"]},{"year":2018,"claim":"High-resolution (1.7 Å) crystal structure of cIAP1 RING dimer with UBE2D2~Ub conjugate plus backside ubiquitin provided the most complete structural snapshot of RING-induced closed E2~Ub conformation primed for transfer, revealing how backside ubiquitin contacts the α1β1-loop to further stabilize the active state.","evidence":"X-ray crystallography at 1.7 Å with in vitro ubiquitin transfer assays","pmids":["30523153"],"confidence":"High","gaps":["How closed conformation promotes aminolysis vs hydrolysis not fully explained","Dynamics of transition between open and closed states not captured"]},{"year":2022,"claim":"Structure of MUL1 RING with UBE2D2 showed that RING binding induces the closed E2~Ub conformation and accelerates ubiquitin transfer onto p53-TAD, with the N77A mutation pre-forming the closed state — establishing that conformational priming is a general RING-mediated activation mechanism across diverse E3 ligases.","evidence":"Crystal structure of RING(MUL1):UBE2D2, oxyester hydrolysis kinetics, binding affinity measurements","pmids":["35048531"],"confidence":"High","gaps":["In vivo relevance of MUL1-mediated p53 ubiquitination via UBE2D2 not shown","Whether N77A phenocopies RING activation in cellular context untested"]},{"year":2023,"claim":"UBE2D2 was identified as a regulator of VEGFR2 proteolysis in endothelial cells: its depletion increased surface VEGFR2, enhanced VEGF-A signaling, and promoted tubulogenesis, extending UBE2D2 function to angiogenic receptor turnover.","evidence":"siRNA screen, surface biotinylation, recycling assays, tubulogenesis assay in endothelial cells","pmids":["37226882"],"confidence":"Medium","gaps":["E3 ligase partnering with UBE2D2 for VEGFR2 ubiquitination not identified","Redundancy with UBE2D1 not fully resolved","In vivo angiogenesis phenotype not tested"]},{"year":2024,"claim":"Engineered ubiquitin variants that specifically bind UBE2D2 at the E1-binding site and backside ubiquitin-binding surface inhibit chain building, providing tool reagents and confirming that both interfaces are functionally essential for E2 activity.","evidence":"Structural and biophysical characterization, in vitro ubiquitin chain-building inhibition, mutagenesis","pmids":["39473070"],"confidence":"High","gaps":["UbV inhibitors not tested in cellular systems","Selectivity against all UBE2D paralogs not fully mapped"]},{"year":null,"claim":"Major open questions include: the structural and kinetic basis for UBE2D2 selectivity among its many E3 partners in vivo; how cells regulate UBE2D2 allocation across competing RING and HECT pathways; and whether paralog-specific functions exist within the UBE2D family that cannot be captured by single-gene knockdown.","evidence":"","pmids":[],"confidence":"Low","gaps":["No paralog-selective knockout or degron studies in mammalian systems","No global substrate profiling for UBE2D2 specifically","No disease-causing mutations in UBE2D2 identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,2,5,6,8,13,15]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,5,6,8,11,12,16,25]},{"term_id":"GO:0031386","term_label":"protein tag activity","supporting_discovery_ids":[0,13,15]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,6,8]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[16]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[12,23]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,5,6,8,11,13,15,16,22,25]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,12,23]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[16,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,8]}],"complexes":[],"partners":["MDM2","UBE3A","CBL","CHIP","PRKN","CIAP1","MUL1","UBE4B"],"other_free_text":[]},"mechanistic_narrative":"UBE2D2 (UbcH5B) is a broadly acting E2 ubiquitin-conjugating enzyme that partners with both RING-type and HECT-type E3 ligases to ubiquitinate diverse substrates, functioning in protein quality control, signal transduction, cell-cycle progression, receptor trafficking, and mitophagy. Its conserved UBC domain harbors a catalytic cysteine in a surface cleft that forms a thioester intermediate with ubiquitin; RING E3 binding (demonstrated with c-Cbl, cIAP1, APC11, MUL1, AO7/RNF25, and E4B) induces a closed E2~Ub conformation that primes ubiquitin transfer, while non-covalent ubiquitin binding to the E2 backside stimulates chain-building activity [PMID:30523153, PMID:26475854, PMID:39473070]. UBE2D2 serves as the cognate E2 for Mdm2-dependent p53 degradation, E6AP/E6-mediated p53 ubiquitination, SCF(β-TrCP)-catalyzed IκBα ubiquitination, CHIP-mediated phospho-tau ubiquitination, c-Cbl-driven EGFR ubiquitination, and Parkin-dependent ubiquitination of mitochondrial outer membrane proteins during mitophagy [PMID:15280377, PMID:7724550, PMID:10918611, PMID:14612456, PMID:18508924, PMID:24906799]. In RING E3 pathways UBE2D2 acts predominantly as a monoubiquitin-initiating E2, whereas it supports polyubiquitin chain elongation in HECT E3 pathways, and its essential cellular function in yeast maps to cooperation with HECT-type ligases [PMID:21357418]."},"prefetch_data":{"uniprot":{"accession":"P62837","full_name":"Ubiquitin-conjugating enzyme E2 D2","aliases":["(E3-independent) E2 ubiquitin-conjugating enzyme D2","E2 ubiquitin-conjugating enzyme D2","Ubiquitin carrier protein D2","Ubiquitin-conjugating enzyme E2(17)KB 2","Ubiquitin-conjugating enzyme E2-17 kDa 2","Ubiquitin-protein ligase D2","p53-regulated ubiquitin-conjugating enzyme 1"],"length_aa":147,"mass_kda":16.7,"function":"Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins (PubMed:10329681, PubMed:18042044, PubMed:18703417, PubMed:20061386, PubMed:20403326, PubMed:20525694, PubMed:26475854, PubMed:28322253). Catalyzes 'Lys-48'-linked polyubiquitination (PubMed:10329681, PubMed:18042044, PubMed:18359941, PubMed:18703417, PubMed:20061386, PubMed:20403326, PubMed:20525694, PubMed:26475854). Mediates the selective degradation of short-lived and abnormal proteins (PubMed:10329681, PubMed:18042044, PubMed:18359941, PubMed:18703417, PubMed:20061386, PubMed:20403326, PubMed:20525694, PubMed:26475854). Functions in the E6/E6-AP-induced ubiquitination of p53/TP53 (PubMed:15280377). Mediates ubiquitination of PEX5 and SQSTM1 and autoubiquitination of STUB1 and TRAF6 (PubMed:18359941, PubMed:28322253). Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by RIGI in response to viral infection (PubMed:18703417, PubMed:20403326). Essential for viral activation of IRF3 (PubMed:19854139)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P62837/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UBE2D2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/UBE2D2","total_profiled":1310},"omim":[{"mim_id":"621515","title":"UBIQUITIN-CONJUGATING ENZYME E2 D4; UBE2D4","url":"https://www.omim.org/entry/621515"},{"mim_id":"616386","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 17; KCTD17","url":"https://www.omim.org/entry/616386"},{"mim_id":"616014","title":"RING FINGER PROTEIN 25; RNF25","url":"https://www.omim.org/entry/616014"},{"mim_id":"614534","title":"ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; ANAPC11","url":"https://www.omim.org/entry/614534"},{"mim_id":"614472","title":"RING FINGER PROTEIN 123; RNF123","url":"https://www.omim.org/entry/614472"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/UBE2D2"},"hgnc":{"alias_symbol":["UbcH5B","UBC4"],"prev_symbol":[]},"alphafold":{"accession":"P62837","domains":[{"cath_id":"3.10.110.10","chopping":"1-147","consensus_level":"medium","plddt":96.4914,"start":1,"end":147}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P62837","model_url":"https://alphafold.ebi.ac.uk/files/AF-P62837-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P62837-F1-predicted_aligned_error_v6.png","plddt_mean":96.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UBE2D2","jax_strain_url":"https://www.jax.org/strain/search?query=UBE2D2"},"sequence":{"accession":"P62837","fasta_url":"https://rest.uniprot.org/uniprotkb/P62837.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P62837/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P62837"}},"corpus_meta":[{"pmid":"2154373","id":"PMC_2154373","title":"Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2154373","citation_count":447,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10922056","id":"PMC_10922056","title":"The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10922056","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15280377","id":"PMC_15280377","title":"Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15280377","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15062086","id":"PMC_15062086","title":"Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches.","date":"2004","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/15062086","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7724550","id":"PMC_7724550","title":"Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP).","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7724550","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24906799","id":"PMC_24906799","title":"The ubiquitin-conjugating enzymes UBE2N, UBE2L3 and UBE2D2/3 are essential for Parkin-dependent mitophagy.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24906799","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20152160","id":"PMC_20152160","title":"Crystal structure of UbcH5b~ubiquitin intermediate: insight into the formation of the self-assembled E2~Ub conjugates.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/20152160","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18508924","id":"PMC_18508924","title":"Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18508924","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8268156","id":"PMC_8268156","title":"Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4.","date":"1993","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8268156","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10875339","id":"PMC_10875339","title":"The Ustilago maydis ubc4 and ubc5 genes encode members of a MAP kinase cascade required for filamentous growth.","date":"2000","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/10875339","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32756532","id":"PMC_32756532","title":"Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p.","date":"2020","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/32756532","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10419697","id":"PMC_10419697","title":"Activation of a UBC4-dependent pathway of ubiquitin conjugation during postnatal development of the rat testis.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10419697","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8754804","id":"PMC_8754804","title":"A novel rat homolog of the Saccharomyces cerevisiae ubiquitin-conjugating enzymes UBC4 and UBC5 with distinct biochemical features is induced during spermatogenesis.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8754804","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8419375","id":"PMC_8419375","title":"A major ubiquitin conjugation system in wheat germ extracts involves a 15-kDa ubiquitin-conjugating enzyme (E2) homologous to the yeast UBC4/UBC5 gene products.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8419375","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20696396","id":"PMC_20696396","title":"Molecular basis for the association of human E4B U box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/20696396","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10918611","id":"PMC_10918611","title":"SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10918611","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16118187","id":"PMC_16118187","title":"Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 binds the proteasome in the presence of translationally damaged proteins.","date":"2005","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16118187","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15522302","id":"PMC_15522302","title":"Solution structure of the ubiquitin-conjugating enzyme UbcH5B.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15522302","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26475854","id":"PMC_26475854","title":"Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26475854","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12724408","id":"PMC_12724408","title":"Two ubiquitin-conjugating enzymes, UbcP1/Ubc4 and UbcP4/Ubc11, have distinct functions for ubiquitination of mitotic cyclin.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12724408","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33607208","id":"PMC_33607208","title":"Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33607208","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21324894","id":"PMC_21324894","title":"Nuclear protein quality is regulated by the ubiquitin-proteasome system through the activity of Ubc4 and San1 in fission yeast.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21324894","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18202552","id":"PMC_18202552","title":"Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18202552","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21357418","id":"PMC_21357418","title":"The essential Ubc4/Ubc5 function in yeast is HECT E3-dependent, and RING E3-dependent pathways require only monoubiquitin transfer by Ubc4.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21357418","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16275319","id":"PMC_16275319","title":"Expression, purification, and properties of the Ubc4/5 family of E2 enzymes.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16275319","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7756256","id":"PMC_7756256","title":"The yeast UBC4 ubiquitin conjugating enzyme monoubiquitinates itself in vivo: evidence for an E2-E2 homointeraction.","date":"1995","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7756256","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16024774","id":"PMC_16024774","title":"Mice lacking the UBC4-testis gene have a delay in postnatal testis development but normal spermatogenesis and fertility.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16024774","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18703417","id":"PMC_18703417","title":"Ubiquitin-conjugating enzyme UBE2D2 is responsible for FBXW2 (F-box and WD repeat domain containing 2)-mediated human GCM1 (glial cell missing homolog 1) ubiquitination and degradation.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18703417","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20660159","id":"PMC_20660159","title":"Ubc4 and Not4 regulate steady-state levels of DNA polymerase-α to promote efficient and accurate DNA replication.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20660159","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33812169","id":"PMC_33812169","title":"miR-30b-5p releases HMGB1 via UBE2D2/KAT2B/HMGB1 pathway to promote pro-inflammatory polarization and recruitment of macrophages.","date":"2021","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/33812169","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30523153","id":"PMC_30523153","title":"Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B∼ubiquitin complex.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30523153","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8391479","id":"PMC_8391479","title":"Selective ubiquitination of calmodulin by UBC4 and a putative ubiquitin protein ligase (E3) from Saccharomyces cerevisiae.","date":"1993","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8391479","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27378730","id":"PMC_27378730","title":"UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27378730","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11255249","id":"PMC_11255249","title":"Yeast 2 microm plasmid copy number is elevated by a mutation in the nuclear gene UBC4.","date":"2001","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11255249","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7698660","id":"PMC_7698660","title":"Schizosaccharomyces pombe and Candida albicans cDNA homologues of the Saccharomyces cerevisiae UBC4 gene.","date":"1995","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7698660","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35196197","id":"PMC_35196197","title":"Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35196197","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35048531","id":"PMC_35048531","title":"MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/35048531","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18466927","id":"PMC_18466927","title":"The ubiquitin-conjugating enzymes, Ubc4 and Cdc34, mediate cadmium resistance in budding yeast through different mechanisms.","date":"2008","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18466927","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19809202","id":"PMC_19809202","title":"A functional analysis of the yeast ubiquitin ligase Rsp5: the involvement of the ubiquitin-conjugating enzyme Ubc4 and poly-ubiquitination in ethanol-induced down-regulation of targeted proteins.","date":"2009","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19809202","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17397110","id":"PMC_17397110","title":"Dosage rescue by UBC4 restores cell wall integrity in Saccharomyces cerevisiae lacking the myosin type II gene MYO1.","date":"2007","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17397110","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35722711","id":"PMC_35722711","title":"Circ_UBE2D2 Attenuates the Progression of Septic Acute Kidney Injury in Rats by Targeting miR-370-3p/NR4A3 Axis.","date":"2022","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35722711","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37226882","id":"PMC_37226882","title":"The E2 ubiquitin-conjugating enzymes UBE2D1 and UBE2D2 regulate VEGFR2 dynamics and endothelial function.","date":"2023","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/37226882","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36232444","id":"PMC_36232444","title":"Arabidopsis Ubiquitin-Conjugating Enzymes UBC4, UBC5, and UBC6 Have Major Functions in Sugar Metabolism and Leaf Senescence.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36232444","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36557625","id":"PMC_36557625","title":"Ubiquitin-Conjugating Enzymes Ubc1 and Ubc4 Mediate the Turnover of Hap4, a Master Regulator of Mitochondrial Biogenesis in Saccharomyces cerevisiae.","date":"2022","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/36557625","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31929179","id":"PMC_31929179","title":"The RING domain of mitochondrial E3 ubiquitin ligase 1 and its complex with Ube2D2: crystallization and X-ray diffraction.","date":"2020","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/31929179","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35384721","id":"PMC_35384721","title":"RPS12 and UBC4 Are Related to Senescence Signal Production in the Ribosomal RNA Gene Cluster.","date":"2022","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35384721","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25670855","id":"PMC_25670855","title":"Rad25 protein is targeted for degradation by the Ubc4-Ufd4 pathway.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25670855","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35751189","id":"PMC_35751189","title":"E2UbcH5B-derived peptide ligands target HECT E3-E2 binding site and block the Ub-dependent SARS-CoV-2 egression: A computational study.","date":"2022","source":"Computers in biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35751189","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31820282","id":"PMC_31820282","title":"Construction and Characterization of UBC4 Mutants with Single Residues Swapped from UBC5.","date":"2019","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31820282","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36426069","id":"PMC_36426069","title":"Quantitative proteome dataset profiling of UBC4 and UBC5 deletion strains in Saccharomyces cerevisiae.","date":"2022","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/36426069","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40912429","id":"PMC_40912429","title":"UBE2D2 promotes gastric cancer progression by inhibiting ferroptosis through autophagy-dependent stabilization of CST1.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40912429","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39473070","id":"PMC_39473070","title":"Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2.","date":"2024","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/39473070","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39826694","id":"PMC_39826694","title":"Rad5 and Ubc4 directly ubiquitinate PCNA at Lys164 in vitro.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39826694","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39597624","id":"PMC_39597624","title":"Proteome Profiling of S. cerevisiae Strains Lacking the Ubiquitin-Conjugating Enzymes Ubc4 and Ubc5 During Exponential Growth and After Heat Shock Treatment.","date":"2024","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/39597624","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.08.669440","title":"Regulation of macroautophagy and microautophagic lipophagy by phosphatidylserine synthase Cho1 and external ethanolamine","date":"2025-08-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.08.669440","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.11.19.624306","title":"Identification and characterization of a ubiquitin E3 RING ligase of the<i>Chlamydia</i>-like bacterium<i>Simkania negevensis</i>","date":"2024-11-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.19.624306","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"24292625","id":"PMC_24292625","title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24292625","citation_count":1480,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10722742","id":"PMC_10722742","title":"Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10722742","citation_count":890,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10514377","id":"PMC_10514377","title":"The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10514377","citation_count":862,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24968937","id":"PMC_24968937","title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/24968937","citation_count":732,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18213395","id":"PMC_18213395","title":"Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18213395","citation_count":644,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17006537","id":"PMC_17006537","title":"A ubiquitin ligase complex assembles linear polyubiquitin chains.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17006537","citation_count":643,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15103385","id":"PMC_15103385","title":"The ubiquitin ligase COP1 is a critical negative regulator of p53.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15103385","citation_count":587,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14690596","id":"PMC_14690596","title":"Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14690596","citation_count":573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10562557","id":"PMC_10562557","title":"SUMO-1 modification activates the transcriptional response of p53.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10562557","citation_count":554,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16547522","id":"PMC_16547522","title":"Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16547522","citation_count":528,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12150907","id":"PMC_12150907","title":"CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.","date":"2002","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12150907","citation_count":405,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17460044","id":"PMC_17460044","title":"Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17460044","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14612456","id":"PMC_14612456","title":"CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14612456","citation_count":390,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11907583","id":"PMC_11907583","title":"TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11907583","citation_count":389,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20864041","id":"PMC_20864041","title":"MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20864041","citation_count":388,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11641273","id":"PMC_11641273","title":"A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11641273","citation_count":387,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11724934","id":"PMC_11724934","title":"The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11724934","citation_count":366,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14593114","id":"PMC_14593114","title":"Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14593114","citation_count":326,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":28383,"output_tokens":5719,"usd":0.085467},"stage2":{"model":"claude-opus-4-6","input_tokens":9364,"output_tokens":4127,"usd":0.224993},"total_usd":0.676839,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":40823,"output_tokens":7710,"usd":0.119059},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10981,"output_tokens":4399,"usd":0.24732}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"UBC4 and UBC5 (yeast orthologs of UBE2D2) mediate selective degradation of short-lived and abnormal proteins by generating high molecular weight ubiquitin-protein conjugates in vivo; loss of both enzymes impairs turnover of short-lived proteins and canavanyl-peptides but not long-lived proteins.\",\n      \"method\": \"Genetic deletion (ubc4ubc5 mutants), in vivo ubiquitin conjugation assays, growth phenotype analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — foundational genetic and biochemical study, replicated across many subsequent papers\",\n      \"pmids\": [\"2154373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Crystal structure of yeast Ubc4 at 2.7 Å revealed an α/β protein with four α-helices and a four-stranded antiparallel β-sheet; the ubiquitin-accepting cysteine is located in a cleft between two loops, and the conserved surface adjacent to the catalytic cysteine functions in protein-protein binding during ubiquitin thiol ester formation.\",\n      \"method\": \"X-ray crystallography, molecular replacement\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional inference about catalytic cysteine environment\",\n      \"pmids\": [\"8268156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Human UBC4 (UBE2D2 ortholog) specifically ubiquitinates E6-associated protein (E6AP) and reconstitution with purified components demonstrated that UBC4, E6AP, and E6 are required for p53 ubiquitinylation; in vivo inhibition of UBC4 blocks E6-stimulated p53 degradation.\",\n      \"method\": \"In vitro reconstitution of ubiquitinylation with purified components, in vivo inhibition assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with purified components plus in vivo validation\",\n      \"pmids\": [\"7724550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Yeast UBC4 is monoubiquitinated in vivo at K144, dependent on active UBC4 transferring ubiquitin intermolecularly from one UBC4 monomer to another (E2-E2 homointeraction); cross-linking confirmed direct UBC4 self-interaction in vitro.\",\n      \"method\": \"In vivo epitope-tagged ubiquitin co-expression, site-directed mutagenesis, chemical mapping, cross-linking\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single study demonstrating E2 self-ubiquitination and homointeraction\",\n      \"pmids\": [\"7756256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"APC11 (RING-H2 finger protein) and UBC4 (UBE2D2 ortholog) are sufficient to ubiquitinate APC substrates securin and cyclin B in vitro; APC11 alone supports multiubiquitin chain synthesis with UBC4 in the presence of E1, and the integrity of the RING-H2 finger is required for this activity.\",\n      \"method\": \"In vitro ubiquitination assay with recombinant proteins, mass spectrometric identification, RING domain mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis validation\",\n      \"pmids\": [\"10922056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"UBC4 (UBE2D2 ortholog) and Ubc3 catalyze phosphorylation-dependent ubiquitination of IκBα in a SCFβ-TRCP-dependent manner; UBC4 associates with SCFβ-TRCP complex and is 19-fold more efficient than Ubc3 in catalyzing IκBα ubiquitination in vitro.\",\n      \"method\": \"In vitro reconstitution with recombinant components, co-immunoprecipitation with SCFβ-TRCP, quantitative activity comparison\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with purified components plus complex association data\",\n      \"pmids\": [\"10918611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In fission yeast, UbcP1/Ubc4 (UBE2D2 ortholog) functions nonredundantly with UbcP4/Ubc11 in APC/C-mediated degradation of mitotic cyclin Cdc13; UbcP1/Ubc4 specifically elongates short ubiquitin chains on Cdc13 while UbcP4/Ubc11 initiates ubiquitination.\",\n      \"method\": \"Genetic analysis (ubc4 mutants), in vivo ubiquitination state analysis, high-expression suppression experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with defined mechanistic roles, replicated in multiple organisms\",\n      \"pmids\": [\"12724408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UbcH5B (UBE2D2) interacts with the CNOT4 RING domain E3 ubiquitin ligase; NMR chemical shift perturbation identified the residues of UbcH5B important for CNOT4 binding, and structural models of the complex revealed differences from the c-Cbl/UbcH7 complex explaining E2/E3 specificity.\",\n      \"method\": \"NMR chemical shift perturbation, docking (HADDOCK), mutagenesis\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural study with mutagenesis and computational docking\",\n      \"pmids\": [\"15062086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Solution structure of UbcH5B (UBE2D2) solved by NMR; the N-terminal helix involved in E3 binding displays a different position compared to crystal structures, and multiple conformations of Asn77 side-chain (single hydrogen-bonded in crystals) suggest functional relevance for catalysis.\",\n      \"method\": \"NMR spectroscopy (relaxation data, automated NOE assignments, homology modeling)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure determination with functional inference\",\n      \"pmids\": [\"15522302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UbcH5B and UbcH5C (UBE2D2 and UBE2D3) are the E2 enzymes that support Mdm2-mediated ubiquitination of p53 and Mdm2 auto-ubiquitination; siRNA knockdown of UbcH5B/C causes accumulation of both Mdm2 and p53 in unstressed cells and inhibits p53 ubiquitination and degradation.\",\n      \"method\": \"In vitro E2 panel screen, siRNA knockdown, immunoblot for ubiquitination and protein levels\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro screen combined with siRNA loss-of-function in cells, replicated across orthogonal methods\",\n      \"pmids\": [\"15280377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UBE2D2 is the E2 ubiquitin-conjugating enzyme required for SCF(FBXW2)-mediated ubiquitination and proteasomal degradation of GCM1 (glial cell missing homolog 1) in placental cells; UBE2D2 enzyme activity is required for GCMa ubiquitination, UBE2D2 associates with the SCF(FBXW2) complex, and UBE2D2 knockdown prolongs GCM1 half-life in vivo.\",\n      \"method\": \"In vitro ubiquitination assay with E2 panel screen, co-immunoprecipitation with SCF complex, RNA interference knockdown, half-life measurement\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods: in vitro assay, co-IP, RNAi loss-of-function with protein stability readout\",\n      \"pmids\": [\"18703417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ubc4/5 (UBE2D2 orthologs) and c-Cbl cooperate to ubiquitinate EGFR; upon EGF stimulation, Ubc4/5 relocates with c-Cbl from plasma membrane to Hrs-positive endosomes, continuing EGFR ubiquitination after internalization to facilitate polyubiquitination required for Hrs-dependent lysosomal sorting.\",\n      \"method\": \"Localization analysis, knockdown, in vitro ubiquitination activity, time-course ubiquitination experiments\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — localization, knockdown, and in vitro activity combined with mechanistic pathway placement\",\n      \"pmids\": [\"18508924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of UbcH5b~ubiquitin intermediate at 2.2 Å reveals an infinite spiral assembled through backside interaction of E2~Ub conjugates; this self-assembled complex provides multiple E2 active sites enabling efficient substrate ubiquitination by bridging the gap between substrate lysine and E2 catalytic cysteine.\",\n      \"method\": \"X-ray crystallography, in vitro biochemical ubiquitination assays\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with biochemical validation of functional model\",\n      \"pmids\": [\"20152160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"E4B U box domain binds UbcH5c and Ubc4 (UBE2D2 family) as a monomer stabilized by a hydrogen bond network; structural studies and calorimetry suggest allosteric regulation of UbcH5c and Ubc4 by E4B U box binding.\",\n      \"method\": \"X-ray crystallography, NMR spectroscopy, calorimetry (ITC), NMR-based binding assays\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure, NMR, and calorimetry combined in single study\",\n      \"pmids\": [\"20696396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The essential function of Ubc4/Ubc5 (UBE2D2 orthologs) in yeast is through a HECT E3-dependent pathway (likely Rsp5), not RING E3 pathways; a mutation (N78S) eliminating RING E3-catalyzed isopeptide formation but not HECT transthiolation rescues lethality, while Ubc4 acts as a monoubiquitinating E2 in RING E3 pathways.\",\n      \"method\": \"Genetic rescue with point mutants, in vitro ubiquitination assays with RING and HECT E3s\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis combined with biochemical mechanistic dissection using specific separation-of-function mutants\",\n      \"pmids\": [\"21357418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"UBE2D2 (along with UBE2D3) is required for Parkin-dependent mitophagy; UBE2D2 knockdown significantly reduces autophagic clearance of depolarized mitochondria and reduces ubiquitination of mitochondrial substrates (mitofusins, TOM20, TOM70, VDAC1, Parkin) without affecting PINK1 stabilization or Parkin translocation.\",\n      \"method\": \"siRNA knockdown, mitophagy assay (autophagic flux), immunofluorescence, ubiquitination assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic knockdown with multiple substrate readouts and pathway position defined\",\n      \"pmids\": [\"24906799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RING E3 AO7 (RNF25) binds UbcH5B (UBE2D2) with high affinity via a unique UbcH5B binding region (U5BR) that forms a clamp surrounding the E2, interacting with the backside of UbcH5B distinct from the active site and RING-interacting region; this high-affinity binding blocks stimulatory non-covalent ubiquitin binding to the E2 backside, thereby paradoxically decreasing ubiquitination rate.\",\n      \"method\": \"Co-crystallization, X-ray crystallography, in vitro ubiquitination assays, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-crystal structure with mutagenesis and biochemical validation\",\n      \"pmids\": [\"26475854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"UBE2D2 does not functionally interact with MuRF1 E3 ligase in muscle atrophy; UBE2D2 showed no affinity for MuRF1 by yeast two-hybrid or Surface Plasmon Resonance, and was unable to promote degradation of MuRF1 substrate α-actin in cells, while UBE2D2 mRNA was repressed during muscle atrophy.\",\n      \"method\": \"Yeast two-hybrid, Surface Plasmon Resonance (SPR), cell-based degradation assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple binding methods demonstrating absence of interaction, negative finding\",\n      \"pmids\": [\"27378730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of cIAP1 RING dimer bound to UbcH5B covalently linked to ubiquitin (UbcH5B-Ub) and a noncovalent ubiquitin at 1.7 Å; cIAP1 RING promotes closed UbcH5B-Ub conformation priming the thioester for transfer, while noncovalent ubiquitin binding to the backside of UbcH5B abuts the α1β1-loop to further stabilize the active closed conformation.\",\n      \"method\": \"X-ray crystallography, biochemical ubiquitination assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with biochemical analysis of mechanism\",\n      \"pmids\": [\"30523153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"UbcH5b (UBE2D2) supports HECTD3 auto-ubiquitination in vitro; compound PC3-15 directly binds UbcH5b and inhibits UbcH5b-mediated p62 ubiquitination; the UbcH5b-p62 axis promotes autophagy-mediated resistance to lapatinib in triple-negative breast cancer.\",\n      \"method\": \"In vitro ubiquitination assay (FRET-based), direct binding assay, cell-based autophagy and drug sensitivity assays, mouse xenograft\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro biochemical assays with cell-based and in vivo validation\",\n      \"pmids\": [\"33607208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"UBE2D2 acts upstream of KAT2B in endothelial cells; miR-30b-5p reduces UBE2D2 ubiquitination activity, stabilizing KAT2B which then acetylates HMGB1 promoting its nuclear exit and secretion to drive macrophage pro-inflammatory polarization.\",\n      \"method\": \"Luciferase reporter assay, co-immunoprecipitation, ubiquitination assay, flow cytometry, Transwell assay\",\n      \"journal\": \"Atherosclerosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods but pathway complexity and single-lab study\",\n      \"pmids\": [\"33812169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MUL1 RING domain recruits substrate p53-TAD as a complex with UBE2D2~ubiquitin thioester; RING(MUL1) binding induces closed conformation of UBE2D2~Ub, accelerating hydrolysis; p53-TAD binding affinity is enhanced when presented with RING(MUL1):UBE2D2~Ub complex rather than either component alone, involving multivalency.\",\n      \"method\": \"Crystal structure of RING(MUL1):UBE2D2 complex, oxyester mimetics, NMR/biophysical binding assays, mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with biochemical and biophysical mechanistic analysis\",\n      \"pmids\": [\"35048531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UBE2D2 (and UBE2D1) regulate VEGFR2 ubiquitination, trafficking, and proteolysis in endothelial cells; depletion of UBE2D2 raises steady-state VEGFR2 levels at the plasma membrane by increasing receptor recycling, enhancing VEGF-A signaling (MAPK, PLCγ1, Akt) and promoting endothelial tubulogenesis.\",\n      \"method\": \"Reverse genetics siRNA screen, cell-surface biotinylation, recycling assays, immunoblot signaling analysis, tubulogenesis assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic screen with multiple orthogonal assays defining mechanism and functional consequence\",\n      \"pmids\": [\"37226882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Ubiquitin variants (UbVs) that bind Ube2d2 (UbcH5b) at two sites — one overlapping the E1-binding site and one blocking the non-covalent ubiquitin backside-binding site — inhibit ubiquitin chain building with low micromolar affinity and high specificity within the Ube2d family.\",\n      \"method\": \"Structural characterization, biophysical binding assays, in vitro ubiquitin chain-building assays, specificity profiling\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — structural and biophysical characterization with functional inhibition assays\",\n      \"pmids\": [\"39473070\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UBE2D2 (UbcH5B/C, ortholog of yeast Ubc4/5) is a broadly active E2 ubiquitin-conjugating enzyme that forms a thioester intermediate with ubiquitin at its catalytic cysteine, adopts a closed/active conformation upon RING E3 binding (structurally defined for cIAP1, AO7, MUL1, E4B), and transfers ubiquitin to substrates including p53 (via Mdm2 and MUL1), IκBα (via SCFβ-TRCP), GCM1 (via SCF-FBXW2), EGFR (via c-Cbl), and VEGFR2; it supports Parkin-dependent mitophagy and p62-mediated autophagy, with its activity stimulated by non-covalent ubiquitin binding to the backside of the E2, and it is regulated by E3-mediated allosteric conformational changes that prime the thioester bond for ubiquitin transfer.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper and extract discoveries only from KEEP papers.\n\n**Classification notes:**\n- Papers [10] and [43] from corpus: Ustilago maydis ubc4/ubc5 are MAP kinase cascade genes (not E2 ubiquitin-conjugating enzymes) — EXCLUDE (symbol collision)\n- Papers [11] (circ_UBE2D2 breast cancer), [36] (circ-UBE2D2 NSCLC), [41] (circ_UBE2D2 kidney) — EXCLUDE (alt-locus circRNA products)\n- Paper [35] (S. pombe/C. albicans UBC4 cDNA cloning only) — EXCLUDE (no mechanistic finding)\n- Paper [14] (wheat germ E2) — borderline plant ortholog; functionally consistent with UBC4/5 family but wheat-specific biochemistry; EXCLUDE (plant, not mammalian/model organism ortholog)\n- Additional gene2pubmed papers [1,2,3,4,5,6,7,8,9,10,11,12,13,15,17,18,19,20,21,23,24] — most describe other genes (CRBN, cDNA sequencing, DUBs, interactomes, NF-κB, p53-SUMO, etc.) without specific UBE2D2 mechanistic content — EXCLUDE unless they directly describe UBE2D2 mechanism\n- Additional [25] (CHIP-UbcH5B ubiquitinates tau) — KEEP (UbcH5B = UBE2D2)\n- Additional [26] (c-IAP1/TRAF2) — uses UbcH5 family but doesn't specifically identify UBE2D2 — borderline; checking... describes c-IAP1 E3 activity, doesn't specifically name UBE2D2 — EXCLUDE\n- Additional [6] (Mdm2 RING E3, uses E2s including UbcH5) — KEEP if UBE2D2 specifically named; the abstract mentions E1 and E2 generically — EXCLUDE (no specific UBE2D2 mention)\n- Additional [7] (c-Cbl E3, recruits E2) — mentions Ubc4/5 indirectly via RPTK ubiquitination — EXCLUDE (no specific UBE2D2)\n- Additional [16] (COP1/p53) — no specific UBE2D2 mention — EXCLUDE\n- Additional [22] (CHIP/Parkin) — no specific UBE2D2 — EXCLUDE\n- Additional [27] (MAGE-RING) — no specific UBE2D2 — EXCLUDE\n- Additional [14] (MULAN/mitochondrial E3) — relevant context but no specific UBE2D2 mechanism — will check corpus paper [6] instead\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"Yeast UBC4 and UBC5 (orthologues of human UBE2D2) are ubiquitin-conjugating enzymes that mediate selective degradation of short-lived and abnormal proteins; they are heat-inducible, generate high-molecular-weight ubiquitin-protein conjugates in vivo, and their loss impairs cell growth and stress tolerance.\",\n      \"method\": \"Genetic deletion (ubc4ubc5 mutants), in vivo ubiquitin conjugation assays, protein turnover measurements\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — foundational study with multiple orthogonal methods; replicated across many subsequent studies\",\n      \"pmids\": [\"2154373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The three-dimensional structure of yeast Ubc4 (UBE2D2 orthologue) was solved at 2.7 Å; it is an α/β protein with four α-helices and a four-stranded antiparallel β-sheet, with the ubiquitin-accepting catalytic cysteine located in a cleft between two loops. Tertiary structure is highly conserved among class I E2 enzymes, and a conserved surface adjacent to the catalytic cysteine mediates protein-protein interactions during ubiquitin thioester formation.\",\n      \"method\": \"X-ray crystallography (molecular replacement, 2.7 Å resolution)\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional interpretation, foundational structural paper\",\n      \"pmids\": [\"8268156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Human UBC4 (UBE2D2) specifically ubiquitinates E6-associated protein (E6AP) and is required for HPV E6/E6AP-mediated ubiquitination and degradation of p53 in vitro; inhibition of UBC4 activity in vivo blocks E6-stimulated p53 degradation, defining UBC4 as the E2 in this pathway.\",\n      \"method\": \"Reconstitution of ubiquitination from purified components, in vivo inhibition assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution from purified components with in vivo validation\",\n      \"pmids\": [\"7724550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Yeast UBC4 monoubiquitinates itself in vivo at Lys144 via an intermolecular (E2–E2) reaction requiring a second lysine (K64) and direct homointeraction between UBC4 monomers, demonstrating E2–E2 interactions as a general phenomenon.\",\n      \"method\": \"Epitope-tagged ubiquitin co-expression, site-directed mutagenesis, chemical mapping, cross-linking analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal mutagenesis and cross-linking in single study\",\n      \"pmids\": [\"7756256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"c-Cbl functions as a RING-type E3 ubiquitin ligase that recruits and allosterically activates an E2 ubiquitin-conjugating enzyme (Ubc4/5 family, including UBE2D2 orthologue) through its RING domain to ubiquitinate tyrosine-phosphorylated receptor protein-tyrosine kinase substrates.\",\n      \"method\": \"In vitro ubiquitination assays, co-immunoprecipitation, RING domain mutagenesis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted activity with mutagenesis, highly cited foundational paper\",\n      \"pmids\": [\"10514377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"APC11 (RING-H2 finger subunit of the APC/C) together with UBC4 (UBE2D2 orthologue) is sufficient to ubiquitinate APC/C substrates cyclin B and securin in vitro, and to synthesize multiubiquitin chains; the integrity of the RING-H2 finger is required for this activity.\",\n      \"method\": \"Reconstitution of ubiquitination with recombinant proteins, mass spectrometry identification, RING domain mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with mutagenesis validation\",\n      \"pmids\": [\"10922056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"UBC4 (UBE2D2 orthologue) cooperates with SCF(β-TRCP) E3 complex to catalyze phosphorylation-dependent ubiquitination of IκBα in a reconstituted system; Ubc4 is 19-fold more efficient than Ubc3/CDC34 in this reaction and is in excess over Ubc3 in THP.1 cells, suggesting it is the preferentially used E2 in vivo. Both E2s associate physically with the SCF(β-TRCP) complex.\",\n      \"method\": \"Reconstitution of IκBα ubiquitination from recombinant components, co-immunoprecipitation with SCF complex from human cells, activity comparison assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with quantitative comparison and co-IP validation\",\n      \"pmids\": [\"10918611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In fission yeast, UbcP1/Ubc4 (UBE2D2 orthologue) and UbcP4/Ubc11 play non-redundant, essential roles in mitotic cyclin Cdc13 degradation via APC/C; Ubc4 specifically elongates short ubiquitin chains initiated by UbcP4/Ubc11, demonstrating distinct roles for the two E2s in polyubiquitin chain assembly on APC/C substrates.\",\n      \"method\": \"Genetic analysis (mutant phenotypes, non-complementation), in vivo ubiquitination state analysis of Cdc13\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with direct in vivo ubiquitination analysis, replicated in multiple genetic contexts\",\n      \"pmids\": [\"12724408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UbcH5B (UBE2D2) supports Mdm2-mediated ubiquitination of p53 and Mdm2 auto-ubiquitination in vitro; siRNA knockdown of UbcH5B/C in cells causes accumulation of both Mdm2 and p53, inhibits p53 ubiquitination and degradation, identifying UbcH5B/C as physiological E2s for Mdm2 in maintaining low p53/Mdm2 levels in unstressed cells.\",\n      \"method\": \"In vitro E2 panel screen, siRNA knockdown, p53/Mdm2 protein level and ubiquitination analysis in intact cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution plus RNAi with cellular phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"15280377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The solution structure of UbcH5B (UBE2D2) was determined by NMR; the structure shows the conserved E2 fold but with a distinct orientation of the N-terminal helix (involved in E3 binding) compared to crystal structures, and conformational freedom of the catalytic Asn77 side chain, which may have implications for catalytic mechanism.\",\n      \"method\": \"NMR spectroscopy (homology modeling, relaxation data, automated NOE assignments)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure determination with functional discussion\",\n      \"pmids\": [\"15522302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The structural model of the UbcH5B (UBE2D2)/CNOT4 RING complex was determined by NMR chemical shift perturbation mapping of UbcH5B residues important for CNOT4 binding, combined with HADDOCK docking; the model reveals E2/E3 interface residues and differences from the c-Cbl/UbcH7 complex that underlie E2–E3 specificity.\",\n      \"method\": \"NMR chemical shift perturbation experiments, computational docking (HADDOCK), mutagenesis\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR-driven structural model with mutagenesis validation\",\n      \"pmids\": [\"15062086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UBE2D2 is responsible for SCF(FBXW2)-mediated ubiquitination and proteasomal degradation of the placental transcription factor GCM1; UBE2D2 enzyme activity is required for GCMa ubiquitination, UBE2D2 associates with the SCF(FBXW2) complex, and RNAi knockdown of UBE2D2 prolongs GCM1 half-life in vivo.\",\n      \"method\": \"In vitro ubiquitination assay screen, co-immunoprecipitation, RNAi knockdown with protein half-life measurement\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution, co-IP, and RNAi with substrate stabilization in cells\",\n      \"pmids\": [\"18703417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ubc4/5 (UBE2D2 orthologue) cooperates with c-Cbl E3 ligase to ubiquitinate the EGF receptor (EGFR) both at the plasma membrane and after internalization on Hrs-positive endosomes; sustained EGFR tyrosine phosphorylation facilitates polyubiquitination in endosomes, which is required for efficient Hrs interaction and lysosomal sorting.\",\n      \"method\": \"Localization studies (fluorescence microscopy), siRNA knockdown, in vitro ubiquitination assays, time-course analysis of EGFR ubiquitination and trafficking\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including knockdown, localization, and in vitro activity\",\n      \"pmids\": [\"18508924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of UbcH5b (UBE2D2)~ubiquitin intermediate at 2.2 Å reveals the E2~Ub conjugate self-assembles into an infinite spiral through a backside interaction; this assembly provides multiple active E2 sites, and biochemical assays support a model in which self-assembled UbcH5b~Ub bridges the gap between substrate lysine and the E2 catalytic cysteine to enable efficient ubiquitination.\",\n      \"method\": \"X-ray crystallography (2.2 Å), in vitro ubiquitination assays\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus biochemical validation in one study\",\n      \"pmids\": [\"20152160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The E4B U box domain (E3/E4 ubiquitin ligase) binds UbcH5c and Ubc4 (UBE2D2 family) as a monomer; crystal and NMR structures of E4B U box free and bound to UbcH5c/Ubc4 reveal an allosteric regulation of the E2 enzymes by E4B U box, providing a molecular basis for assembly of the ubiquitylation machinery involving E4B.\",\n      \"method\": \"X-ray crystallography, NMR spectroscopy, calorimetry-based binding assays\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple structural methods plus biophysical binding measurements\",\n      \"pmids\": [\"20696396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In yeast, the essential function of Ubc4/Ubc5 (UBE2D2 orthologues) is with a HECT-type E3 (likely the essential HECT E3 Rsp5), not RING E3s; the N78S mutation selectively eliminating RING-catalyzed isopeptide bond formation (but not HECT transthiolation) rescues the lethal ubc4/ubc5 deletion. In RING E3-catalyzed pathways Ubc4 acts as a monoubiquitinating E2, and backside ubiquitin binding (S23R mutation) has no observable in vivo effect.\",\n      \"method\": \"Yeast genetic rescue assays with point mutations, in vitro reconstitution distinguishing HECT vs RING pathways\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic epistasis combined with biochemical reconstitution and mutagenesis\",\n      \"pmids\": [\"21357418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"UBE2D2 (along with UBE2N and UBE2L3) is required for Parkin-dependent mitophagy; knockdown of UBE2D2/UBE2D3 reduces autophagic clearance of depolarized mitochondria without affecting PINK1 stabilization or Parkin translocation. Combined knockdown of all three E2s significantly reduces mitochondrial polyubiquitylation and p62 recruitment. UBE2D2 contributes to ubiquitination of mitofusins, TOM20, TOM70, VDAC1, and Parkin itself.\",\n      \"method\": \"siRNA knockdown, mitophagy assays, ubiquitination analysis of mitochondrial substrates, epistasis analysis with Parkin C431S mutant\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple knockdowns with defined mitochondrial substrate phenotypes and epistasis with Parkin active-site mutant\",\n      \"pmids\": [\"24906799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The RING E3 AO7 (RNF25) binds UbcH5B (UBE2D2) with unusually high affinity via a unique UbcH5B-binding region (U5BR) connected to the RING domain, forming a clamp surrounding the E2 and engaging both the RING-interacting surface and the backside of UbcH5B. High-affinity clamp binding paradoxically decreases ubiquitination rate by blocking stimulatory non-covalent ubiquitin binding to the UbcH5B backside; when backside binding cannot occur, the clamp enhances ubiquitination.\",\n      \"method\": \"Co-crystallization of AO7/UbcH5B complex, mutagenesis of RING-E2 interface, in vitro ubiquitination rate assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-crystal structure plus functional mutagenesis and quantitative activity assays\",\n      \"pmids\": [\"26475854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"UBE2D2 does not interact with the muscle-specific E3 ligase MuRF1 (no binding detected by yeast two-hybrid or Surface Plasmon Resonance) and is unable to promote degradation of the MuRF1 substrate α-actin in cells; UBE2D2 mRNA is progressively repressed during muscle atrophy, making it a poor candidate for MuRF1-dependent muscle wasting.\",\n      \"method\": \"Yeast two-hybrid, Surface Plasmon Resonance, HEK293T cell degradation assays, mRNA expression analysis during hindlimb suspension\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal binding assays plus functional cell assay, single lab\",\n      \"pmids\": [\"27378730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of cIAP1 RING dimer bound to UbcH5B (UBE2D2) covalently linked to ubiquitin and a noncovalent ubiquitin at 1.7 Å reveals that cIAP1 RING promotes a closed UbcH5B~Ub conformation priming the thioester for transfer; noncovalent ubiquitin binds the backside of UbcH5B and contacts the α1β1-loop, further stabilizing the closed active conformation.\",\n      \"method\": \"X-ray crystallography (1.7 Å), in vitro ubiquitin transfer assays, biochemical analysis of UbcH5B conformation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with biochemical validation\",\n      \"pmids\": [\"30523153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"UbcH5b (UBE2D2) strongly supports HECTD3 auto-ubiquitination in vitro; the triterpenoid PC3-15 directly binds UbcH5b and inhibits UbcH5b-mediated ubiquitination. The UbcH5b–p62 axis confers TNBC resistance to lapatinib by promoting autophagy; PC3-15 inhibits lapatinib-induced autophagy and restores lapatinib sensitivity in vitro and in mouse xenografts.\",\n      \"method\": \"FRET-based ubiquitination assay, direct binding assay (PC3-15 to UbcH5b), p62 ubiquitination assay, cell viability/autophagy assays, xenograft experiments\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro assays with direct binding and in vivo xenograft validation, single lab\",\n      \"pmids\": [\"33607208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-30b-5p upregulated by ox-LDL reduces UBE2D2 ubiquitination activity, leading to stabilization of KAT2B, which promotes HMGB1 acetylation, nuclear exit, and secretion from endothelial cells, driving pro-inflammatory M1 macrophage polarization; UBE2D2 thus acts upstream of KAT2B in this inflammatory signaling pathway.\",\n      \"method\": \"Luciferase reporter assay (miR-30b-5p binding to UBE2D2), co-IP, ubiquitination assays, flow cytometry, Transwell migration\",\n      \"journal\": \"Atherosclerosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple methods but pathway mechanistic chain depends on several steps, single lab\",\n      \"pmids\": [\"33812169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The RING domain of MUL1 (mitochondrial E3 ligase) recruits UBE2D2 and the substrate p53-TAD as a ternary complex; RING(MUL1) binding induces closed conformation of UBE2D2~Ub and strongly accelerates hydrolysis (ubiquitin transfer); the N77A mutation of UBE2D2 pre-forms the closed conformation even without RING(MUL1). TADp53 binding affinity is enhanced when presented to the RING(MUL1):UBE2D2~Ub complex (multivalent recognition of disordered substrate).\",\n      \"method\": \"Crystal structure determination (RING(MUL1):UBE2D2 complex), oxyester hydrolysis assays, binding affinity measurements, UBE2D2 mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mutagenesis and quantitative biochemical assays in one study\",\n      \"pmids\": [\"35048531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UBE2D2 (and UBE2D1) regulate VEGFR2 ubiquitination and proteolysis in endothelial cells; depletion of UBE2D2 increases steady-state and plasma membrane VEGFR2 levels, enhances VEGF-A-stimulated MAPK/PLCγ1/Akt signaling, increases VEGFR2 recycling to the plasma membrane, and stimulates endothelial tubulogenesis.\",\n      \"method\": \"Reverse genetics siRNA screen, surface biotinylation, recycling assays, western blotting, tubulogenesis assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cellular methods with defined receptor trafficking phenotype, single lab\",\n      \"pmids\": [\"37226882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Ubiquitin variants (UbVs) that bind Ube2d2 (UbcH5b) with low micromolar affinity and high specificity were identified; structural and biophysical characterization shows two UbVs inhibit ubiquitin chain building — one blocks the E1-binding site and a second additional site blocks non-covalent ubiquitin backside binding on Ube2d2, demonstrating the functional importance of both interfaces for E2 activity.\",\n      \"method\": \"Structural characterization, biophysical binding assays, in vitro ubiquitin chain-building inhibition assays, mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural and biophysical characterization with functional inhibition assays\",\n      \"pmids\": [\"39473070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CHIP E3 ubiquitin ligase together with Hsc70 and the E2 enzyme UbcH5B (UBE2D2) ubiquitinates phosphorylated tau (an Alzheimer's disease-associated modification); phosphorylation of tau is a recognition requirement for CHIP/UbcH5B-mediated ubiquitination, and CHIP rescues phosphorylated tau-induced cell death.\",\n      \"method\": \"In vitro ubiquitination assay (co-incubation of purified components), cell death rescue assay, comparison with other E3 ligases\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified components, functional cell rescue, specificity demonstrated by comparison with other E3s\",\n      \"pmids\": [\"14612456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UBE2D2 promotes gastric cancer progression by supporting autophagy-dependent stabilization of CST1 (Cystatin SN); UBE2D2 knockdown destabilizes GPx4 via the CST1 axis, enhancing ROS accumulation and ferroptosis. UBE2D2 knockdown suppresses GC cell proliferation, invasion, migration, and EMT in vitro and in vivo.\",\n      \"method\": \"Proteomic screening, UBE2D2 knockdown in vitro and in vivo (xenograft), ferroptosis assays (ROS, GPx4), mechanistic pathway validation\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — knockdown with defined pathway and substrate, single lab, mechanistic chain involves multiple steps\",\n      \"pmids\": [\"40912429\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UBE2D2 (UbcH5B/UBC4) is a broadly acting E2 ubiquitin-conjugating enzyme whose conserved UBC domain harbors a catalytic cysteine in a surface cleft; it forms thioester intermediates with ubiquitin that adopt a stimulatory closed conformation upon RING E3 binding (structurally defined with APC11, cIAP1, AO7, MUL1, and E4B), supports ubiquitination of diverse substrates (p53 via Mdm2/E6AP/MUL1/COP1, GCM1 via SCF-FBXW2, IκBα via SCF-β-TRCP, EGFR via c-Cbl, phospho-tau via CHIP, mitofusins/TOM20/TOM70 via Parkin, and VEGFR2) through both RING and HECT E3 ligases, functions as a monoubiquitinating initiator in RING pathways while performing polyubiquitin chain elongation in HECT-dependent pathways, and is regulated by non-covalent ubiquitin backside binding that stimulates its activity as well as by miR-30b-5p-mediated suppression in inflammatory contexts.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"UBE2D2 (UbcH5B) is a broadly active E2 ubiquitin-conjugating enzyme that partners with both RING and HECT E3 ligases to mediate selective degradation of short-lived, abnormal, and regulatory proteins across multiple cellular pathways. It forms a thioester intermediate with ubiquitin at its catalytic cysteine and adopts a closed, catalytically primed conformation upon RING E3 binding (demonstrated for cIAP1, MUL1, E4B, and AO7/RNF25), with non-covalent ubiquitin binding to the E2 backside further stabilizing this active state and promoting polyubiquitin chain elongation [PMID:30523153, PMID:35048531, PMID:26475854, PMID:20152160]. UBE2D2 functions as the cognate E2 for SCF-type (IκBα via SCFβ-TRCP, GCM1 via SCF-FBXW2), RING-type (Mdm2 for p53, c-Cbl for EGFR, MUL1 for p53), and HECT-type E3 ligases, and supports APC/C-mediated ubiquitin chain elongation on mitotic substrates [PMID:10918611, PMID:10922056, PMID:15280377, PMID:18508924, PMID:14]. It is required for Parkin-dependent mitophagy downstream of PINK1, ubiquitinating mitochondrial outer membrane substrates, and promotes p62-mediated autophagy; it also controls VEGFR2 surface levels by directing receptor ubiquitination and lysosomal trafficking in endothelial cells [PMID:24906799, PMID:33607208, PMID:37226882].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing that the UBC4/5 family selectively targets short-lived and abnormal proteins for ubiquitin-dependent degradation answered the foundational question of which E2 enzymes handle quality-control proteolysis.\",\n      \"evidence\": \"Genetic deletion of UBC4/UBC5 in yeast with in vivo ubiquitin conjugation and turnover assays\",\n      \"pmids\": [\"2154373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian orthologs not yet characterized\", \"Specific E3 partners unknown\", \"Substrate recognition mechanism undefined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Solving the crystal structure of Ubc4 revealed the conserved E2 fold and the catalytic cysteine environment, providing the structural framework for understanding E2–E1 and E2–E3 interactions.\",\n      \"evidence\": \"X-ray crystallography of yeast Ubc4 at 2.7 Å\",\n      \"pmids\": [\"8268156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No E2–E3 or E2–Ub complex structures yet\", \"Conformational dynamics during catalysis unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that human UBC4 is the specific E2 for E6AP-mediated p53 ubiquitination established UBE2D2 as a physiological E2 in mammalian substrate-targeted degradation, and the discovery of E2 self-ubiquitination via homointeraction revealed an additional regulatory dimension.\",\n      \"evidence\": \"In vitro reconstitution with purified E1/E2/E3/substrate; in vivo inhibition; cross-linking and mutagenesis of K144\",\n      \"pmids\": [\"7724550\", \"7756256\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of E2 self-ubiquitination unclear\", \"No RING E3 structures with UBE2D2\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showing that UBE2D2 supports both APC/C-mediated cyclin/securin ubiquitination and SCFβ-TRCP-mediated IκBα ubiquitination established it as a versatile E2 spanning cell cycle and NF-κB signaling pathways.\",\n      \"evidence\": \"In vitro reconstitution with APC11 RING and SCFβ-TRCP; co-immunoprecipitation; quantitative activity comparison with Ubc3\",\n      \"pmids\": [\"10922056\", \"10918611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for E2–RING selectivity not resolved\", \"In vivo requirement for APC/C pathway not proven in mammals\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"NMR solution structure of UbcH5B and identification of the CNOT4 and Mdm2 RING-binding surfaces, combined with siRNA evidence that UbcH5B/C are required for p53 and Mdm2 turnover in cells, defined the structural determinants of E2–RING E3 specificity and confirmed physiological relevance.\",\n      \"evidence\": \"NMR spectroscopy, chemical shift perturbation, mutagenesis, siRNA knockdown with immunoblot readouts\",\n      \"pmids\": [\"15062086\", \"15522302\", \"15280377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the E2~Ub thioester intermediate\", \"Allosteric activation mechanism by RING binding not yet visualized\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of UBE2D2 as the cognate E2 for c-Cbl-mediated EGFR ubiquitination and SCF(FBXW2)-mediated GCM1 degradation, with demonstrations of E2 relocalization from plasma membrane to endosomes during EGFR sorting, expanded the substrate repertoire and placed UBE2D2 in receptor trafficking.\",\n      \"evidence\": \"Localization analysis, knockdown, in vitro E2 panel screen, co-IP with SCF complex, half-life measurements\",\n      \"pmids\": [\"18508924\", \"18703417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for c-Cbl/UBE2D2 interaction not resolved\", \"Whether UBE2D2 is essential versus redundant for EGFR sorting in vivo unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The crystal structure of UbcH5b~Ub conjugate revealed a self-assembling spiral mediated by backside ubiquitin binding, explaining how non-covalent ubiquitin interaction promotes processive polyubiquitination, and E4B U-box structural studies showed allosteric regulation of the E2 by E3 binding.\",\n      \"evidence\": \"X-ray crystallography at 2.2 Å, ITC, NMR-based binding, in vitro ubiquitination assays\",\n      \"pmids\": [\"20152160\", \"20696396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of the spiral assembly in cells not demonstrated\", \"How different RING/U-box E3s differentially utilize backside binding unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A separation-of-function mutant (N78S) that abolishes RING-dependent isopeptide bond formation but preserves HECT transthiolation revealed that the essential yeast function of Ubc4/5 operates through HECT E3 pathways, reframing the relative importance of RING vs. HECT partnerships.\",\n      \"evidence\": \"Genetic rescue of ubc4Δubc5Δ lethality with point mutants, in vitro ubiquitination with RING and HECT E3s\",\n      \"pmids\": [\"21357418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this HECT-dependent essentiality applies in mammalian cells untested\", \"Specific HECT E3 substrates mediating viability not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing UBE2D2 as a required E2 for Parkin-dependent mitophagy placed it in a disease-relevant organelle quality-control pathway, acting downstream of PINK1 to ubiquitinate mitochondrial outer membrane proteins.\",\n      \"evidence\": \"siRNA knockdown, mitophagy autophagic flux assay, immunofluorescence, ubiquitination assays for mitofusins/TOM20/TOM70/VDAC1\",\n      \"pmids\": [\"24906799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBE2D2 initiates chains or elongates them during mitophagy not resolved\", \"Redundancy with UBE2D3 not fully delineated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The co-crystal structure of AO7/RNF25 with UbcH5B revealed a unique high-affinity binding clamp on the E2 backside that competes with stimulatory non-covalent ubiquitin, establishing that backside occupancy is a regulatory switch controlling ubiquitination rate.\",\n      \"evidence\": \"Co-crystallization, mutagenesis, in vitro ubiquitination rate measurements\",\n      \"pmids\": [\"26475854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates of the AO7–UBE2D2 pair unknown\", \"In vivo relevance of backside competition not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The 1.7 Å structure of cIAP1 RING dimer with UbcH5B~Ub and backside ubiquitin provided the most complete view of the catalytically primed closed conformation, showing how RING dimerization and backside ubiquitin cooperatively stabilize the active E2~Ub conformation.\",\n      \"evidence\": \"X-ray crystallography at 1.7 Å resolution with biochemical ubiquitination assays\",\n      \"pmids\": [\"30523153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transition-state geometry not captured\", \"How closed conformation accelerates aminolysis vs. hydrolysis not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of the UbcH5b–p62 ubiquitination axis in autophagy-mediated drug resistance, and of UBE2D2-dependent KAT2B degradation controlling HMGB1 acetylation in endothelial inflammation, extended UBE2D2's functional scope to autophagy and vascular biology.\",\n      \"evidence\": \"FRET-based ubiquitination assay, direct binding assays, xenograft models; co-IP, ubiquitination assays in endothelial cells\",\n      \"pmids\": [\"33607208\", \"33812169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether UBE2D2 directly ubiquitinates p62 or acts through an E3 not defined\", \"KAT2B as a direct UBE2D2 substrate not confirmed with purified components\", \"Single-lab findings for each axis\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Structural and biophysical analysis of MUL1 RING with UBE2D2~Ub revealed that the E3 enhances substrate p53-TAD recruitment through multivalent interactions with the preformed RING:E2~Ub complex, establishing a substrate-capture mechanism.\",\n      \"evidence\": \"Crystal structure of RING(MUL1):UBE2D2 complex, oxyester mimetics, NMR and biophysical binding assays\",\n      \"pmids\": [\"35048531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of MUL1-mediated p53 ubiquitination via UBE2D2 not established\", \"Generality of multivalent substrate capture to other RING E3s unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that UBE2D2 depletion increases VEGFR2 plasma membrane levels by enhancing receptor recycling and amplifying downstream VEGF-A signaling defined UBE2D2 as a negative regulator of angiogenic receptor trafficking.\",\n      \"evidence\": \"Reverse genetics siRNA screen, cell-surface biotinylation, recycling assays, tubulogenesis assay\",\n      \"pmids\": [\"37226882\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which E3 ligase partners UBE2D2 for VEGFR2 ubiquitination not identified\", \"Redundancy with UBE2D1 not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Engineering ubiquitin variants that selectively inhibit UBE2D2 by binding the E1-interaction surface and the backside ubiquitin-binding site provided pharmacological-grade tools and validated both sites as druggable regulatory surfaces.\",\n      \"evidence\": \"Structural characterization, biophysical binding assays, specificity profiling across UBE2D family, chain-building inhibition assays\",\n      \"pmids\": [\"39473070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cell-based or in vivo validation of ubiquitin variant inhibitors reported\", \"Small-molecule druggability of these sites not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis for how UBE2D2 selects among its many E3 partners in vivo, whether backside ubiquitin-mediated E2~Ub oligomerization occurs physiologically, the degree of functional redundancy among UBE2D family members, and whether UBE2D2 loss-of-function causes human disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No disease-causing mutations in UBE2D2 reported\", \"In vivo E2–E3 pairing rules not defined\", \"Physiological relevance of E2~Ub spiral/oligomer not tested in cells\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 2, 4, 5, 9, 10, 11, 15, 21]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 5, 9, 10, 15, 21, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [9, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 5, 9, 10, 15, 22]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [15, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 11, 22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\n      \"SCFβ-TRCP\",\n      \"SCF-FBXW2\",\n      \"APC/C\"\n    ],\n    \"partners\": [\n      \"MDM2\",\n      \"PRKN\",\n      \"CBL\",\n      \"CNOT4\",\n      \"UBE3A\",\n      \"MUL1\",\n      \"UBE4B\",\n      \"RNF25\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"UBE2D2 (UbcH5B) is a broadly acting E2 ubiquitin-conjugating enzyme that partners with both RING-type and HECT-type E3 ligases to ubiquitinate diverse substrates, functioning in protein quality control, signal transduction, cell-cycle progression, receptor trafficking, and mitophagy. Its conserved UBC domain harbors a catalytic cysteine in a surface cleft that forms a thioester intermediate with ubiquitin; RING E3 binding (demonstrated with c-Cbl, cIAP1, APC11, MUL1, AO7/RNF25, and E4B) induces a closed E2~Ub conformation that primes ubiquitin transfer, while non-covalent ubiquitin binding to the E2 backside stimulates chain-building activity [PMID:30523153, PMID:26475854, PMID:39473070]. UBE2D2 serves as the cognate E2 for Mdm2-dependent p53 degradation, E6AP/E6-mediated p53 ubiquitination, SCF(β-TrCP)-catalyzed IκBα ubiquitination, CHIP-mediated phospho-tau ubiquitination, c-Cbl-driven EGFR ubiquitination, and Parkin-dependent ubiquitination of mitochondrial outer membrane proteins during mitophagy [PMID:15280377, PMID:7724550, PMID:10918611, PMID:14612456, PMID:18508924, PMID:24906799]. In RING E3 pathways UBE2D2 acts predominantly as a monoubiquitin-initiating E2, whereas it supports polyubiquitin chain elongation in HECT E3 pathways, and its essential cellular function in yeast maps to cooperation with HECT-type ligases [PMID:21357418].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Identification of UBC4/UBC5 in yeast established that a dedicated family of E2 enzymes mediates selective degradation of short-lived and abnormal proteins under stress, providing the first functional framework for UBE2D2 orthologues.\",\n      \"evidence\": \"Genetic deletion of yeast ubc4/ubc5 with in vivo ubiquitin conjugation and protein turnover assays\",\n      \"pmids\": [\"2154373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian orthologues not yet characterized\", \"E3 partners unknown\", \"Substrate specificity determinants undefined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"The crystal structure of Ubc4 at 2.7 Å revealed the canonical α/β E2 fold with the catalytic cysteine positioned in a surface cleft between two loops, explaining how the active site is accessible for thioester formation and E3 interaction.\",\n      \"evidence\": \"X-ray crystallography of yeast Ubc4 at 2.7 Å resolution\",\n      \"pmids\": [\"8268156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No E3-bound structure yet\", \"Mechanism of ubiquitin transfer from thioester not resolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Biochemical reconstitution demonstrated that human UBE2D2 is the specific E2 for E6AP/E6-mediated p53 ubiquitination and degradation, establishing UBE2D2 as a physiologically relevant E2 in a disease-linked HECT E3 pathway.\",\n      \"evidence\": \"Reconstitution from purified components with in vivo inhibition of E2 activity\",\n      \"pmids\": [\"7724550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RING vs HECT pathway distinction for UBE2D2 not yet made\", \"Self-ubiquitination mechanism unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that c-Cbl RING domain recruits and allosterically activates UBE2D2-family E2s to ubiquitinate receptor tyrosine kinases revealed the paradigm of RING E3-mediated E2 activation, expanded UBE2D2 function to receptor signaling.\",\n      \"evidence\": \"In vitro ubiquitination, co-immunoprecipitation, RING domain mutagenesis\",\n      \"pmids\": [\"10514377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RING-induced E2 activation not yet determined\", \"In vivo confirmation of E2 identity pending\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"UBE2D2 orthologues were shown to function with APC/C (via APC11 RING) for cyclin B/securin ubiquitination and with SCF(β-TrCP) for phospho-IκBα ubiquitination, demonstrating that a single E2 services multiple major cell-cycle and NF-κB signaling E3 complexes.\",\n      \"evidence\": \"Biochemical reconstitution with recombinant APC11 and SCF complexes, quantitative activity comparison\",\n      \"pmids\": [\"10922056\", \"10918611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UBE2D2 initiates or elongates ubiquitin chains in these pathways unresolved\", \"Redundancy among UBE2D family members not dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Two studies established additional physiological E3 partnerships: CHIP/Hsc70 uses UBE2D2 to ubiquitinate phospho-tau, and fission yeast genetics revealed that Ubc4 specifically elongates ubiquitin chains on APC/C substrates after initiation by a distinct E2.\",\n      \"evidence\": \"In vitro reconstitution with purified CHIP/tau; genetic epistasis and in vivo ubiquitination state analysis in S. pombe\",\n      \"pmids\": [\"14612456\", \"12724408\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether chain elongation role applies in mammalian APC/C pathway unknown\", \"Tau ubiquitination in vivo dependence on UBE2D2 not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"UBE2D2 was confirmed as the physiological E2 for Mdm2-dependent p53 ubiquitination by combining in vitro reconstitution with siRNA knockdown that stabilized both p53 and Mdm2 in cells; NMR solution structure provided the first human UBE2D2 atomic model.\",\n      \"evidence\": \"E2 panel screen, siRNA in human cells, NMR structure determination, NMR-based E3-interaction mapping with CNOT4\",\n      \"pmids\": [\"15280377\", \"15522302\", \"15062086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Mdm2 selects UBE2D2 over other E2s in vivo unclear\", \"Catalytic role of Asn77 not experimentally resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"UBE2D2 was linked to receptor trafficking via c-Cbl-mediated EGFR ubiquitination at the plasma membrane and on endosomes, and to placental biology via SCF(FBXW2)-dependent degradation of GCM1, broadening the physiological context of this E2.\",\n      \"evidence\": \"siRNA knockdown with EGFR trafficking analysis; in vitro ubiquitination, co-IP, RNAi with GCM1 half-life measurement\",\n      \"pmids\": [\"18508924\", \"18703417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy between UBE2D family members in EGFR pathway not resolved\", \"Structural basis of SCF(FBXW2)–UBE2D2 interaction not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The 2.2 Å crystal structure of UBE2D2~ubiquitin conjugate revealed a self-assembling spiral mediated by non-covalent backside ubiquitin binding, providing a structural mechanism for how E2~Ub oligomerization bridges substrate lysine to the catalytic cysteine.\",\n      \"evidence\": \"X-ray crystallography at 2.2 Å with in vitro ubiquitination assays\",\n      \"pmids\": [\"20152160\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of spiral assembly in vivo uncertain\", \"Whether all RING E3s use this mechanism unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Yeast genetic dissection revealed that the essential function of UBE2D2 orthologues is with HECT-type E3s (likely Rsp5), not RING E3s, and that UBE2D2 acts as a monoubiquitinating E2 in RING pathways while performing chain elongation in HECT pathways — the N78S mutation selectively ablated RING- but not HECT-dependent activity.\",\n      \"evidence\": \"Yeast genetic rescue with separation-of-function mutations, in vitro reconstitution distinguishing HECT vs RING pathways\",\n      \"pmids\": [\"21357418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this HECT-preference applies in mammalian cells untested\", \"In vivo relevance of backside ubiquitin binding contradicted by S23R having no phenotype\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"UBE2D2 was identified as one of three E2s required for Parkin-dependent mitophagy, contributing to ubiquitination of mitofusins, TOM20, TOM70, VDAC1, and Parkin itself, placing UBE2D2 in the PINK1/Parkin mitochondrial quality control pathway.\",\n      \"evidence\": \"siRNA knockdown with mitophagy assays, mitochondrial substrate ubiquitination analysis, epistasis with Parkin active-site mutant\",\n      \"pmids\": [\"24906799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of UBE2D2 vs UBE2N vs UBE2L3 to specific substrates unclear\", \"Whether UBE2D2 is recruited directly by Parkin RING or indirectly not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Co-crystal structure of AO7/RNF25 with UBE2D2 revealed a unique clamp mechanism where a U5BR region engages the E2 backside, paradoxically inhibiting activity by blocking stimulatory non-covalent ubiquitin binding — demonstrating that E3s can tune E2 activity by competing for the backside surface.\",\n      \"evidence\": \"Co-crystallization, RING-E2 interface mutagenesis, quantitative ubiquitination rate assays\",\n      \"pmids\": [\"26475854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other E3s use analogous clamp mechanisms unknown\", \"Physiological substrates of AO7/UBE2D2 not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"High-resolution (1.7 Å) crystal structure of cIAP1 RING dimer with UBE2D2~Ub conjugate plus backside ubiquitin provided the most complete structural snapshot of RING-induced closed E2~Ub conformation primed for transfer, revealing how backside ubiquitin contacts the α1β1-loop to further stabilize the active state.\",\n      \"evidence\": \"X-ray crystallography at 1.7 Å with in vitro ubiquitin transfer assays\",\n      \"pmids\": [\"30523153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How closed conformation promotes aminolysis vs hydrolysis not fully explained\", \"Dynamics of transition between open and closed states not captured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Structure of MUL1 RING with UBE2D2 showed that RING binding induces the closed E2~Ub conformation and accelerates ubiquitin transfer onto p53-TAD, with the N77A mutation pre-forming the closed state — establishing that conformational priming is a general RING-mediated activation mechanism across diverse E3 ligases.\",\n      \"evidence\": \"Crystal structure of RING(MUL1):UBE2D2, oxyester hydrolysis kinetics, binding affinity measurements\",\n      \"pmids\": [\"35048531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of MUL1-mediated p53 ubiquitination via UBE2D2 not shown\", \"Whether N77A phenocopies RING activation in cellular context untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"UBE2D2 was identified as a regulator of VEGFR2 proteolysis in endothelial cells: its depletion increased surface VEGFR2, enhanced VEGF-A signaling, and promoted tubulogenesis, extending UBE2D2 function to angiogenic receptor turnover.\",\n      \"evidence\": \"siRNA screen, surface biotinylation, recycling assays, tubulogenesis assay in endothelial cells\",\n      \"pmids\": [\"37226882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase partnering with UBE2D2 for VEGFR2 ubiquitination not identified\", \"Redundancy with UBE2D1 not fully resolved\", \"In vivo angiogenesis phenotype not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Engineered ubiquitin variants that specifically bind UBE2D2 at the E1-binding site and backside ubiquitin-binding surface inhibit chain building, providing tool reagents and confirming that both interfaces are functionally essential for E2 activity.\",\n      \"evidence\": \"Structural and biophysical characterization, in vitro ubiquitin chain-building inhibition, mutagenesis\",\n      \"pmids\": [\"39473070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"UbV inhibitors not tested in cellular systems\", \"Selectivity against all UBE2D paralogs not fully mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the structural and kinetic basis for UBE2D2 selectivity among its many E3 partners in vivo; how cells regulate UBE2D2 allocation across competing RING and HECT pathways; and whether paralog-specific functions exist within the UBE2D family that cannot be captured by single-gene knockdown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No paralog-selective knockout or degron studies in mammalian systems\", \"No global substrate profiling for UBE2D2 specifically\", \"No disease-causing mutations in UBE2D2 identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 2, 5, 6, 8, 13, 15]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 5, 6, 8, 11, 12, 16, 25]},\n      {\"term_id\": \"GO:0031386\", \"supporting_discovery_ids\": [0, 13, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 6, 8]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [12, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 5, 6, 8, 11, 13, 15, 16, 22, 25]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 12, 23]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [16, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MDM2\",\n      \"UBE3A\",\n      \"CBL\",\n      \"CHIP\",\n      \"PRKN\",\n      \"CIAP1\",\n      \"MUL1\",\n      \"UBE4B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}